3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
7
Carcinoma, Hepatocellular
6
Liver Neoplasms
5
Pancreatic Neoplasms
4
Lymphatic Metastasis
2
Locally Advanced Pancreatic Cancer
2
Cholangiocarcinoma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unresectable Pancreatic Cancer
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Adenocarcinoma Resectable
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Liver Diseases
1
Laryngeal Neoplasms
1
Hilus Pulmonary Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Extremities Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Renal Cell
1
Bile Duct Neoplasms
1
Interventions
Esophagectomy
9
Radiotherapy
8
Endoscopic Mucosal Resection
7
Standard of Care
6
Exercise
6
Enteral Nutrition
6
Endoscopy
6
Magnetic Resonance Spectroscopy
5
Fluorouracil
5
Cisplatin
5
Surveys and Questionnaires
4
camrelizumab
3
Yoga
3
Radiofrequency Ablation
3
Radiation
3
Preoperative Exercise
3
Practice Guidelines as Topic
3
Fluorodeoxyglucose F18
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Biopsy
3
spartalizumab
2
X-Rays
2
Robotic Surgical Procedures
2
Psychosocial Intervention
2
Psychiatric Rehabilitation
2
Proton Therapy
2
Physical Therapy Modalities
2
Palliative Care
2
Paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Esophageal Neoplasms
×
Electroporation
×
Clear all
NCT02430701
2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA
Completed
30 enrolled